BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3542485)

  • 1. Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.
    Tanrisever B; Santella PJ
    Drugs; 1986; 32 Suppl 3():1-16. PubMed ID: 3542485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.
    Pfeffer M; Jackson A; Ximenes J; de Menezes JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):331-8. PubMed ID: 848940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.
    Leitner F; Goodhines RA; Buck RE; Price KE
    J Antibiot (Tokyo); 1979 Jul; 32(7):718-26. PubMed ID: 541265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of five oral cephalosporins in calves.
    Soback S; Ziv G; Kurtz B; Paz R
    Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGP 9000: a new orally active, broad-spectrum cephalosporin.
    Zak O; Vischer WA; Schenk C; Tosch W; Zimmermann W; Regös J; Suter ER; Kradolfer F; Gelzer J
    J Antibiot (Tokyo); 1976 Jun; 29(6):653-5. PubMed ID: 950320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
    Silver MS; Counts GW; Zeleznik D; Turck M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin.
    Hartstein AI; Patrick KE; Jones SR; Miller MJ; Bryant RE
    Antimicrob Agents Chemother; 1977 Jul; 12(1):93-7. PubMed ID: 883822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.
    Ginsburg CM
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():27-31. PubMed ID: 7142090
    [No Abstract]   [Full Text] [Related]  

  • 9. Biophotometric comparison of cephalexin and cephradine against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM
    Chemotherapy; 1982; 28(1):40-5. PubMed ID: 7035090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of cefadroxil and cephalexin for pneumonia in a rat test model.
    Chisholm DR; DeRegis RG; Behr DA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):105-9. PubMed ID: 3752972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefadroxil, a new broad-spectrum cephalosporin.
    Buck RE; Price KE
    Antimicrob Agents Chemother; 1977 Feb; 11(2):324-30. PubMed ID: 848939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cefadroxil in the therapy of urinary tract infections.
    Wilber RB; DeRegis RG; Fox EJ
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():77-84. PubMed ID: 7142098
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical comparison of cefadroxil, new oral cephalosporin, and cephalexin in uncomplicated urinary tract infection.
    Bolding OT
    Urology; 1978 Sep; 12(3):321-4. PubMed ID: 360561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalosporin treatments of uncomplicated urinary tract infections: caution concerning application to cefadroxil.
    Nguyen HM; Jones RN
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115053. PubMed ID: 32349909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures.
    Welling PG; Selen A; Pearson JG; Kwok F; Rogge MC; Ifan A; Marrero D; Craig WA; Johnson CA
    Biopharm Drug Dispos; 1985; 6(2):147-57. PubMed ID: 4005394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model.
    Schneider P; Tosch W; Maurer M; Zak O
    J Antibiot (Tokyo); 1982 Jul; 35(7):843-9. PubMed ID: 7174537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs".
    Nguyen HM; Graber CJ
    Int J Antimicrob Agents; 2020 Oct; 56(4):106085. PubMed ID: 32659466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.
    Lode H; Stahlmann R; Koeppe P
    Antimicrob Agents Chemother; 1979 Jul; 16(1):1-6. PubMed ID: 475366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.